At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, I gave an oral presentation on a physician-initiated clinical trial of comprehensive, severe chronic lower limb ischemi...
- Mar 20
- 1 min read
At the 25th Annual Meeting of the Japanese Society for Regenerative Medicine, held from March 19th to 20th , our CEO, Kenichi Yamahara, presented on comprehensive angiogenesis therapy for severe chronic lower limb ischemia (CLTI) using ICS-001, which is currently undergoing clinical trials. Furthermore, this technology was also presented at the 8th Regenerative Medicine Industry-Academia Collaboration Technology Auction.
Comments